Current and future treatment options for adult chronic rhinosinusitis: Focus on nasal polyposis

Journal of Allergy and Clinical Immunology

Volumn 136, Issue 6, 2015, Pages 1431-1440

  Bachert, Claus ^a,b   Zhang, Luo ^c,d   Gevaert, Phillippe ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b STOCKHOLM UNIVERSITY   (Sweden)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d BEIJING INSTITUTE OF OTOLARYNGOLOGY   (China)

Author keywords

Chronic rhinosinusitis; GATA 3; gene silencing; humanized and fully human mAbs; IgE; IL 13; IL 4; IL 5; nasal polyps; TH2

Indexed keywords

ACETYLSALICYLIC ACID; CORTICOSTEROID; DEOXYRIBOZYME; DOXYCYCLINE; GLUCOCORTICOID; IMMUNOGLOBULIN E ANTIBODY; INTERLEUKIN 13 ANTIBODY; INTERLEUKIN 4 ANTIBODY; INTERLEUKIN 5; INTERLEUKIN 5 ANTIBODY; LIGELIZUMAB; MACROLIDE; OMALIZUMAB; SODIUM CHLORIDE; TRANSCRIPTION FACTOR GATA 3; GATA3 PROTEIN, HUMAN; MONOCLONAL ANTIBODY;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; ASTHMA; CHRONIC RHINOSINUSITIS; CLINICAL TRIAL (TOPIC); COMORBIDITY; DRUG HYPERSENSITIVITY; HUMAN; LACTOCOCCUS LACTIS; META ANALYSIS (TOPIC); MULTICENTER STUDY (TOPIC); NONHUMAN; NOSE POLYP; PHASE 3 CLINICAL TRIAL (TOPIC); PHENOTYPE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; TRANSGENIC ORGANISM; GENETICS; IMMUNOLOGY; NASAL POLYPS; RHINITIS; SINUSITIS;

ADULT; ANTIBODIES, MONOCLONAL, HUMANIZED; ASPIRIN; ASTHMA; COMORBIDITY; DNA, CATALYTIC; DRUG HYPERSENSITIVITY; GATA3 TRANSCRIPTION FACTOR; HUMANS; LACTOCOCCUS LACTIS; NASAL POLYPS; ORGANISMS, GENETICALLY MODIFIED; RHINITIS; SINUSITIS;

EID: 84951991810     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2015.10.010     Document Type: Review

References (55)

1. J.S. Schiller, J.W. Lucas, and J.A. Peregoy Summary health statistics for US adults: national health interview survey, 2011 Vital Health Stat 10 256 2012 1 218
2. D. Hastan, W.J. Fokkens, C. Bachert, R.B. Newson, J. Bislimovska, A. Bockelbrink, and et al. Chronic rhinosinusitis in Europe - an underestimated disease. A GALEN study Allergy 66 2011 1216 1223
3. W.J. Fokkens, V.J. Lund, J. Mullol, C. Bachert, I. Alobid, F. Baroody, and et al. European position paper on rhinosinusitis and nasal polyps 2012 Rhinol Suppl 23 2012 1 298
4. P. Tomassen, R.B. Newson, R. Hoffmans, W. Fokkens, C. Bachert, P. Burney, and et al. Reliability of symptom criteria and nasal endoscopy in the assessment of chronic rhinosinusitis based on EPOS-guidelines - a GALEN study Allergy 66 2011 556 561
5. Y.S. Kim, N.H. Kim, S.Y. Seong, K.R. Kim, G.B. Lee, and K.S. Kim Prevalence and risk factors of chronic rhinosinusitis in Korea Am J Rhinol Allergy 25 2011 117 121
6. J.B. Shi, Q.L. Fu, H. Zhang, L. Cheng, Y.J. Wang, D.D. Zhu, and et al. Epidemiology of chronic rhinosinusitis: results from a cross-sectional survey in seven Chinese cities Allergy 70 2015 533 539
7. R.R. Pilan, F.R. Pinna, T.F. Bezerra, R.L. Mori, F.G. Padua, R.F. Bento, and et al. Prevalence of chronic rhinosinusitis in Sao Paulo Rhinology 50 2012 129 138
8. R.E. Gliklich, and R. Metson The health impact of chronic sinusitis in patients seeking otolaryngologic care Otolaryngol Head Neck Surg 113 1995 104 109
9. C. Hopkins, J.P. Browne, R. Slack, V. Lund, J. Topham, B. Reeves, and et al. The national comparative audit of surgery for nasal polyposis and chronic rhinosinusitis Clin Otolaryngol 31 2006 390 398
10. N. Bhattacharyya Incremental health care utilization and expenditures for chronic rhinosinusitis in the United States Ann Otol Rhinol Laryngol 120 2011 423 427
11. C. Philpott, C. Hopkins, S. Erskine, N. Kumar, A. Robertson, A. Farboud, and et al. The burden of revision sinonasal surgery in the UK-data from the Chronic Rhinosinusitis Epidemiology Study (CRES): a cross-sectional study BMJ Open 5 2015 e006680
12. A.T. Peters, S. Spector, J. Hsu, D.L. Hamilos, F.M. Baroody, R.K. Chandra, and et al. Diagnosis and management of rhinosinusitis: a practice parameter update Ann Allergy Asthma Immunol 113 2014 347 385
13. C.A. Akdis, C. Bachert, C. Cingi, M.S. Dykewicz, P.W. Hellings, R.M. Naclerio, and et al. Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology J Allergy Clin Immunol 131 2013 1479 1490
14. G.P. Anderson Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease Lancet 372 2008 1107 1119
15. W. Wen, W. Liu, L. Zhang, J. Bai, Y. Fan, W. Xia, and et al. Increased neutrophilia in nasal polyps reduces the response to oral corticosteroid therapy J Allergy Clin Immunol 129 2012 1522 1528
16. N. Mygind, R. Dahl, and C. Bachert Nasal polyposis, eosinophil dominated inflammation, and allergy Thorax 55 suppl 2000 S79 S83
17. P.P. Cao, H.B. Li, B.F. Wang, S.B. Wang, X.J. You, Y.H. Cui, and et al. Distinct immunopathologic characteristics of various types of chronic rhinosinusitis in adult Chinese J Allergy Clin Immunol 124 2009 478 484
18. T. Nakayama, D. Asaka, M. Yoshikawa, T. Okushi, Y. Matsuwaki, H. Moriyama, and et al. Identification of chronic rhinosinusitis phenotypes using cluster analysis Am J Rhinol Allergy 26 2012 172 176
19. H. Lou, Y. Meng, Y. Piao, C. Wang, L. Zhang, and C. Bachert Predictive significance of tissue eosinophilia for nasal polyp recurrence in the Chinese population Am J Rhinol Allergy 29 2015 350 356
20. C. Bachert, P. Gevaert, G. Holtappels, S.G.O. Johansson, and P. van Cauwenberge Total and specific IgE in nasal polyps is related to local eosinophilic inflammation J Allergy Clin Immunol 107 2001 607 614
21. N. Zhang, T. Van Zele, C. Perez-Novo, N. Van Bruaene, G. Holtappels, N. DeRuyck, and et al. Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease J Allergy Clin Immunol 122 2008 961 968
22. T. Chalermwatanachai, N. Zhang, G. Holtappels, and C. Bachert Association of mucosal organisms with patterns of inflammation in chronic rhinosinusitis PLoS One 10 2015 e0136068
23. G.A. Settipane, and F.H. Chafee Nasal polyps in asthma and rhinitis. A review of 6,037 patients J Allergy Clin Immunol 59 1977 17 21
24. C. Bachert, N. Zhang, G. Holtappels, L. De Lobel, P. van Cauwenberge, S. Liu, and et al. Presence of IL-5 protein and IgE antibodies to staphylococcal enterotoxins in nasal polyps is associated with comorbid asthma J Allergy Clin Immunol 126 2010 962 968 e1-6
25. N. Zhang, P. Gevaert, T. van Zele, C. Perez-Novo, J. Patou, G. Holtappels, and et al. An update on the impact of Staphylococcus aureus enterotoxins in chronic sinusitis with nasal polyposis Rhinology 43 2005 162 168
26. P. Gevaert, L. Calus, N. Van Bruaene, T. Van Zele, and C. Bachert Allergic sensitization, high local IL-5 and IgE predict surgical outcome 12 years after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis [abstract] J Allergy Clin Immunol 135 2015 AB238
27. T. Van Zele, G. Holtappels, P. Gevaert, and C. Bachert Differences in initial immunoprofiles between recurrent and non-recurrent chronic rhinosinusitis with nasal polyps Am J Rhinol Allergy 28 2014 192 198
28. D. Lal, and P.H. Hwang Oral corticosteroid therapy in chronic rhinosinusitis without polyposis: a systematic review Int Forum Allergy Rhinol 1 2011 136 143
29. K. Aasbjerg, C. Torp-Pedersen, A. Vaag, and V. Backer Treating allergic rhinitis with depot-steroid injections increase risk of osteoporosis and diabetes Respir Med 107 2013 1852 1858
30. P. Bonfils, P. Halimi, and D. Malinvaud Adrenal suppression and osteoporosis after treatment of nasal polyposis Acta Otolaryngol 126 2006 1195 1200
31. B. Wallwork, W. Coman, A. Mackay-Sim, L. Greiff, and A. Cervin A double-blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis Laryngoscope 116 2006 189 193
32. W.J. Videler, K. van Hee, S.M. Reinartz, C. Georgalas, F.W. van der Meulen, and W.J. Fokkens Longterm low-dose antibiotics in recalcitrant chronic rhinosinusitis: a retrospective analysis Rhinology 50 2012 45 55
33. H.S. Khalil, and D.A. Nunez Functional endoscopic sinus surgery for chronic rhinosinusitis Cochrane Database Syst Rev 3 2006 CD004458
34. A.A. Aukema, P.G. Mulder, and W.J. Fokkens Treatment of nasal polyposis and chronic rhinosinusitis with fluticasone propionate nasal drops reduces need for sinus surgery J Allergy Clin Immunol 115 2005 1017 1023
35. P. Martinez-Devesa, and S. Patiar Oral steroids for nasal polyps Cochrane Database Syst Rev 7 2011 CD005232
36. T. Van Zele, P. Gevaert, G. Holtappels, A. Beule, P.J. Wormald, S. Mayr, and et al. Oral steroids and doxycycline: two different approaches to treat nasal polyps J Allergy Clin Immunol 125 2010 1069 1076.e4
37. D.D. Stevenson, W.W. Pleskow, R.A. Simon, D.A. Mathison, W.R. Lumry, M. Schatz, and et al. Aspirin-sensitive rhinosinusitis asthma: a double-blind crossover study of treatment with aspirin J Allergy Clin Immunol 73 1984 500 507
38. A. Rozsasi, D. Polzehl, T. Deutschle, E. Smith, K. Wiesmiller, H. Riechelmann, and et al. Long-term treatment with aspirin desensitization: a prospective clinical trial comparing 100 and 300 mg aspirin daily Allergy 63 2008 1228 1234
39. K. Dalziel, K. Stein, A. Round, R. Garside, and P. Royle Endoscopic sinus surgery for the excision of nasal polyps: a systematic review of safety and effectiveness Am J Rhinol 20 2006 506 519
40. P. Gevaert, C. Bachert, G. Holtappels, C. Perez Novo, J. Van der Heyden, L. Fransen, and et al. Enhanced Soluble Interleukin 5 Receptor alpha expression in nasal polyposis Allergy 58 2003 371 379
41. H.U. Simon, S. Yousefi, C. Schranz, A. Schapowal, C. Bachert, and K. Blaser Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia J Immunol 158 1997 3902 3908
42. P. Gevaert, N. Van Bruaene, T. Cattaert, K. Van Steen, T. Van Zele, F. Acke, and et al. Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis J Allergy Clin Immunol 128 2011 989 995
43. P. Gevaert, L. Calus, T. Van Zele, K. Blomme, N. De Ruyck, W. Bauters, and et al. Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma J Allergy Clin Immunol 131 2013 110 116
44. M. Humbert, W. Busse, N.A. Hanania, P.J. Lowe, J. Canvin, V.J. Erpenbeck, and et al. Omalizumab in asthma: an update on recent developments J Allergy Clin Immunol Pract 2 2014 525 536.e1
45. J.M. Pinto, N. Mehta, M. DiTineo, J. Wang, F.M. Baroody, and R.M. Naclerio A randomized, double-blind, placebo-controlled trial of anti-IgE for chronic rhinosinusitis Rhinology 48 2010 318 324
46. J.P. Arm, I. Bottoli, A. Skerjanec, D. Floch, A. Groenewegen, S. Maahs, and et al. Pharmacokinetics, pharmacodynamics and safety of QGE031 (ligelizumab), a novel high-affinity anti-IgE antibody, in atopic subjects Clin Exp Allergy 44 2014 1371 1385
47. C. Bachert, M. Wagenmann, U. Hauser, and C. Rudack IL-5 synthesis is upregulated in human nasal polyp tissue J Allergy Clin Immunol 99 1997 837 842
48. P. Gevaert, D. Lang-Loidolt, H. Stammberger, T. Van Zele, G. Holtappels, J. Tavernier, and et al. Nasal Interleukin-5 levels determine the response to anti-interleukin-5 treatment in nasal polyp patients J Allergy Clin Immunol 118 2006 1133 1141
49. S. Wenzel, L. Ford, D. Pearlman, S. Spector, L. Sher, F. Skobieranda, and et al. Dupilumab in persistent asthma with elevated eosinophil levels N Engl J Med 368 2013 2455 2466
50. C. Bachert, L. Mannent, R.M. Naclerio, J. Mullol, B.J. Ferguson, L. Jiao, and et al. Dupilumab in chronic sinusitis with nasal polyposis, with and without asthma EAACI Online Library. Bachert C Jun 6, 2015 104799
51. L.A. Beck, D. Thaçi, J.D. Hamilton, N.M. Graham, T. Bieber, R. Rocklin, and et al. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis N Engl J Med 371 2014 130 139
52. A. Long, A. Rahmaoui, K.J. Rothman, E. Guinan, M. Eisner, M.S. Bradley, and et al. Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumab J Allergy Clin Immunol 134 2014 560 567
53. N. Krug, J.M. Hohlfeld, A.M. Kirsten, O. Kornmann, K.M. Beeh, D. Kappeler, and et al. Allergen-Induced Asthmatic Responses Modified by a GATA-3 Specific DNAzyme N Engl J Med 372 2015 1987 1995
54. S. Sel, M. Wegmann, T. Dicke, S. Sel, W. Henke, A.O. Yildirim, and et al. Effective prevention and therapy of experimental allergic asthma using a GATA-3-specific DNAzyme J Allergy Clin Immunol 121 2008 910 916
55. L.G. Bermúdez-Humarán, C. Aubry, J.P. Motta, C. Deraison, L. Steidler, N. Vergnolle, and et al. Engineering lactococci and lactobacilli for human health Curr Opin Microbiol 16 2013 278 283